199 related articles for article (PubMed ID: 18471886)
1. Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits.
Liu Y; Qin L; Wilson B; Wu X; Qian L; Granholm AC; Crews FT; Hong JS
Neurotoxicology; 2008 Sep; 29(5):864-70. PubMed ID: 18471886
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of an endotoxin on substantia nigra dopamine neurons.
Reinert KR; Umphlet CD; Quattlebaum A; Boger HA
Brain Res; 2014 Apr; 1557():164-70. PubMed ID: 24513404
[TBL] [Abstract][Full Text] [Related]
3. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
4. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
[TBL] [Abstract][Full Text] [Related]
5. [Effects of different doses of levodopa on paraquat-induced neurotoxicity: an experiment with mice].
Du YL; Liu ZG; Chen SD; Lu GQ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(34):2400-3. PubMed ID: 16321246
[TBL] [Abstract][Full Text] [Related]
6. The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study.
Bharatiya R; Bratzu J; Lobina C; Corda G; Cocco C; De Deurwaerdere P; Argiolas A; Melis MR; Sanna F
Behav Brain Res; 2020 Apr; 384():112562. PubMed ID: 32070689
[TBL] [Abstract][Full Text] [Related]
7. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Iravani MM; Sadeghian M; Leung CC; Tel BC; Rose S; Schapira AH; Jenner P
Exp Neurol; 2008 Aug; 212(2):522-31. PubMed ID: 18571649
[TBL] [Abstract][Full Text] [Related]
9. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.
Chang FW; Wang SD; Lu KT; Lee EH
Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960
[TBL] [Abstract][Full Text] [Related]
10. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
11. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.
Mosharov EV; Larsen KE; Kanter E; Phillips KA; Wilson K; Schmitz Y; Krantz DE; Kobayashi K; Edwards RH; Sulzer D
Neuron; 2009 Apr; 62(2):218-29. PubMed ID: 19409267
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of Intranasal IGF-1 against Neonatal Lipopolysaccharide-Induced Neurobehavioral Deficits and Neuronal Inflammation in the Substantia Nigra and Locus Coeruleus of Juvenile Rats.
Tien LT; Lee YJ; Pang Y; Lu S; Lee JW; Tseng CH; Bhatt AJ; Savich RD; Fan LW
Dev Neurosci; 2017; 39(6):443-459. PubMed ID: 28787734
[TBL] [Abstract][Full Text] [Related]
13. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
15. MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations.
Laloux C; Derambure P; Kreisler A; Houdayer E; Bruezière S; Bordet R; Destée A; Monaca C
Exp Brain Res; 2008 Apr; 186(4):635-42. PubMed ID: 18224307
[TBL] [Abstract][Full Text] [Related]
16. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.
Iravani MM; Syed E; Jackson MJ; Johnston LC; Smith LA; Jenner P
Eur J Neurosci; 2005 Feb; 21(4):841-54. PubMed ID: 15787691
[TBL] [Abstract][Full Text] [Related]
17. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
Chadi G; Møller A; Rosén L; Janson AM; Agnati LA; Goldstein M; Ogren SO; Pettersson RF; Fuxe K
Exp Brain Res; 1993; 97(1):145-58. PubMed ID: 7907549
[TBL] [Abstract][Full Text] [Related]
18. Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons.
Yang Y; An J; Wang Y; Luo W; Wang W; Mei X; Wu S; Chen J
Environ Toxicol Pharmacol; 2011 Jan; 31(1):171-8. PubMed ID: 21787683
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
